TITLE

Soluble L-selectin levels predict survival in sepsis

AUTHOR(S)
Seidelin, Jakob B.; Nielsen, Ole H.; Strøm, Jens
PUB. DATE
November 2002
SOURCE
Intensive Care Medicine;Nov2002, Vol. 28 Issue 11, p1613
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective. To evaluate serum soluble L-selectin as a prognostic factor for survival in patients with sepsis. Design. A prospective study of mortality in patients with sepsis whose serum levels of sL-selectin were measured on admission to an intensive care unit (ICU) and 4 days later. Follow-up data on mortality were obtained from the Danish Central Office of Civil Registration. Setting. A tertiary referral university hospital ICU in Copenhagen. Patients. Sixty-three patients meeting the criteria for systemic inflammatory response syndrome (SIRS) with a suspected or verified infection in one or more major organs, and 14 control subjects. Measurements and results. On admission to the ICU the Simplified Acute Physiology Score (SAPS) II was calculated, and relevant microbial cultures were performed. Mortality was registered at various follow-up points: 7 days after admission, at discharge from hospital, and 3 and 12 months after admission. Serum sL-selectin levels were significantly lower in the patients than in the controls. Sepsis nonsurvivors had significantly lower levels than survivors. Efficiency analysis and receiver operation characteristics showed that the ideal cutoff point for sL-selectin as a test for sepsis survival was 470 ng/ml. The accumulated mortality in patients with subnormal sL-selectin levels on admission was significantly increased. No correlation was found between clinical or paraclinical markers, including SAPS II and sL-selectin, and no relationship to the microbial diagnosis was found. Conclusions. Serum sL-selectin is a predictor of survival in patients with sepsis. Those admitted with low sL-selectin (<470 ng/ml) are characterized by a high mortality within the subsequent 12-month period.
ACCESSION #
15729791

 

Related Articles

  • Are small hospitals with small intensive care units able to treat patients with severe sepsis? Reinikainen, Matti; Karlsson, Sari; Varpula, Tero; Parviainen, Ilkka; Ruokonen, Esko; Varpula, Marjut; Ala-Kokko, Tero; Pettilä, Ville // Intensive Care Medicine;Apr2010, Vol. 36 Issue 4, p673 

    To find out whether mortality from sepsis is influenced by the size of the hospital and of the intensive care unit (ICU). In the Finnsepsis study, 470 patients with severe sepsis were identified. The present study is a retrospective subgroup analysis of the Finnsepsis study. Eighteen patients...

  • Erworbene Muskelschwäche des kritisch Kranken. Ponfick, M.; Bösl, K.; Lüdemann-Podubecka, J.; Neumann, G.; Pohl, M.; Nowak, D.A.; Gdynia, H.-J. // Der Nervenarzt;Feb2014, Vol. 85 Issue 2, p195 

    The diagnosis of intensive care unit acquired weakness (ICUAW) in the setting of neurological rehabilitation is steadily increasing. This is due to the fact that the intensive care of patients with sepsis or after cardiac or abdominal surgery is improving. A longer duration of respiratory...

  • Sepsis is increasing in the general population and ITU care may be underutilised. Parsons, A. // Thorax;Oct2007, Vol. 62 Issue 10, p910 

    The article discusses a study which examines several cases of sepsis in the general population in Great Britain. It has been found that sepsis cases in hospitals are increasing. For this reason, some intensive care units (ITU) in the country is expected to be underutilized. Information about the...

  • Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study. José Garnacho-Montero; Carlos Ortiz-Leyba; Inmaculada Herrera-Melero; Teresa Aldabó-Pallás; Aurelio Cayuela-Dominguez; Juan A. Marquez-Vacaro; Jesus Carbajal-Guerrero; Jose L. Garcia-Garmendia // Journal of Antimicrobial Chemotherapy (JAC);Feb2008, Vol. 61 Issue 2, p436 

    Objectives To determine the attributable mortality and excess length of stay (LOS) associated with the use of inadequate empirical antimicrobial therapy in patients with sepsis at admission to the intensive care unit (ICU). Methods A retrospective matched cohort study was performed using a...

  • Intensive Attempts to Maintain Euglycemia Are Harmful to Patients with Severe Sepsis.  // Clinical Infectious Diseases;6/1/2008, Vol. 46 Issue 11, pvi 

    The article reports on the effect of euglycemia maintenance on patients with severe sepsis. Study revealed that the maintenance of blood glucose in critically ill patients who underwent surgery lessened the rate of subsequent mortality rate. It could be attributed to multiple-organ system...

  • Epidemiology of Severe Sepsis Around the World. Angus, Derek C.; Pires Pereira, Carlos Alberto; Silva, Eliezer // Endocrine, Metabolic & Immune Disorders - Drug Targets;Jun2006, Vol. 6 Issue 2, p207 

    Severe sepsis is an ongoing challenge for clinicians and health-care administrators mainly because is associated with a high incidence, mortality rate and costs. In recent years, several epidemiological studies about the incidence of sepsis have come out in different and prestigious journals....

  • Survival Analysis of 314 Episodes of Sepsis in Medical Intensive Care Unit in University Hospital: Impact of Intensive Care Unit Performance and Antimicrobial Therapy. Degoricija, Vesna; Sharma, Mirella; Legac, Ante; Gradišer, Marina; Šefer, Siniša; Vučičević, Željko // Croatian Medical Journal;2006, Vol. 47 Issue 3, p385 

    Aim To evaluate epidemiology of sepsis in medical intensive care unit (ICU) in a university hospital, and the impact of ICU performance and appropriate empirical antibiotic therapy on survival of septic patients. Methods Observational, partly prospective study conducted over 6 years assessed all...

  • Serum Lipopolysaccharide Binding Protein Levels Predict Severity of Lung Injury and Mortality in Patients with Severe Sepsis. Villar, Jesús; Pérez-Méndez, Lina; Espinosa, Elena; Flores, Carlos; Blanco, Jesús; Muriel, Arturo; Basaldúa, Santiago; Muros, Mercedes; Blanch, Lluis; Artigas, Antonio; Kacmarek, Robert M. // PLoS ONE;2009, Vol. 4 Issue 8, p1 

    Background: There is a need for biomarkers insuring identification of septic patients at high-risk for death. We performed a prospective, multicenter, observational study to investigate the time-course of lipopolysaccharide binding protein (LBP) serum levels in patients with severe sepsis and...

  • Genetic Insights into Sepsis: What have we Learned and How will it Help? Wurfel, M. M. // Current Pharmaceutical Design;Jul2008, Vol. 14 Issue 19, p1900 

    Sepsis and septic shock, are complex disorders that are a major cause of mortality in the intensive care unit. In spite of major advances in our understanding of the pathophysiology of sepsis, accurate prediction of susceptibility to sepsis, multi-organ dysfunction, and death, even in the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics